KLRG1 and ovarian carcinoma: We could speculate that the low activity of T cells in immunologically non-responding patients with ovarian cancer may be more affected by their potentially upregulated LAG-3 and KLRG1 coinhibitory/checkpoint receptors than PD-1 receptors.